Anti-metastatic outcome of isoform-specific prolactin receptor targeting in breast cancer
Page 1 of 1
Anti-metastatic outcome of isoform-specific prolactin receptor targeting in breast cancer
Jon Moulton Wed Jun 07, 2017 4:01 pm
Yonezawa T, Chen KH, Ghosh MK, Rivera L, Dill R, Ma L, Villa PA, Kawaminami M, Walker AM. Anti-metastatic outcome of isoform-specific prolactin receptor targeting in breast cancer. Cancer Lett. 2015 Sep 28;366(1):84-92. doi: 10.1016/j.canlet.2015.06.010. Epub 2015 Jun 18.
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Endothelial cell-specific chemotaxis receptor (ECSCR) enhances vascular endothelial growth factor (VEGF) receptor-2/kinase insert domain receptor (KDR) activation and promotes proteolysis of internalized KDR
» Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes
» mRNA for N-Bak, a neuron-specific BH3-only splice isoform of Bak, escapes nonsense-mediated decay and is translationally repressed in the neurons
» An anti-inflammatory NOD-like receptor is required for microglia development
» An Anti-inflammatory NOD-like Receptor Is Required for Microglia Development
» Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes
» mRNA for N-Bak, a neuron-specific BH3-only splice isoform of Bak, escapes nonsense-mediated decay and is translationally repressed in the neurons
» An anti-inflammatory NOD-like receptor is required for microglia development
» An Anti-inflammatory NOD-like Receptor Is Required for Microglia Development
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum